Beth Israel Deaconess Med Ctr — Boston, Massachusetts

Beth Israel Deaconess Med Ctr is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

Beth Israel Deaconess Med Ctr has participated in 37 clinical trials with 2 currently active.

Therapeutic areas: Mycobacterium Avium-intracellulare Infection, HIV Infections, Prostatic Neoplasms.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Glaxo Wellcome, Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beth Israel Deaconess Med Ctr?

Beth Israel Deaconess Med Ctr has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beth Israel Deaconess Med Ctr conducted?

Beth Israel Deaconess Med Ctr has 37 clinical trials on record, with 2 currently active. Their work covers Mycobacterium Avium-intracellulare Infection, HIV Infections, Prostatic Neoplasms.

Is Beth Israel Deaconess Med Ctr accredited by Crixeo Health?

Yes — Beth Israel Deaconess Med Ctr holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Beth Israel Deaconess Med Ctr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.